Lipopolysaccharide-Binding Protein (LBP) and Markers of Acute-Phase Response in Patients with Multiple Organ Dysfunction Syndrome (MODS) following open heart surgery

 

 Buy Article Permissions and Reprints All articles of this category

Cardiopulmonary bypass (CPB) is associated with an immunological injury that may cause pathophysiological alterations in the form of a systemic inflammatory response syndrome (SIRS) or a multiple organ dysfunction syndrome (MODS). Previous studies on this issue have reported different changes of immunological parameters during and after CPB, but there are no reports about the lipopolysaccharide-binding protein (LBP) in relationship to other markers of inflammation in patients with MODS following cardiovascular surgery. In the present study, we investigated the acute-phase response of patients with MODS of infectious and non-infectious origin following open-heart-surgery. Plasma levels of procalcitonin (PCT), c-reactive protein (CRP), interleukin-6 (IL-6), and LBP were measured in the first four postoperative days in 12 adult male patients with the signs of SIRS and two or more organ dysfunctions after myocardial revascularization (MODS-group), and 12 patients without organ insufficiencies (SIRS-group). There were no significant differences regarding age, weight, height, preoperative NYHA-classification, preoperative LVEDP, or the number of anastomosis. Patients with MODS had a significantly longer operation time, duration of ischemia, and duration of extracorporeal circulation. None of the patients in the SIRS group died, whereas in the MODS group, 4 patients died due to septic multiorgan failure. Plasma PCT and IL-6 concentrations were significantly elevated in all MODS patients. CRP and LBP showed no differences between the MODS and the SIRS group. Comparing the MODS patients with and without positive microbial findings, we found significantly elevated levels of PCT and LBP in those patients with documented infections. Our results indicate that LBP may be a new marker for the differentiation between a severe non-infectious SIRS and an ongoing bacterial sepsis in the early postoperative course following CPB, while a microbiological result is still missing.

References

• 1 Bone R C, Balk R A, Cerra F C. et al . Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.  Chest. 1992;  101 1644-1655
  CrossrefPubMedGoogle Scholar
• 2 Taylor K M. SIRS - The systemic inflammatory response syndrome after cardiac operations.  Ann Thorac Surg. 1996;  61 1607-1608
  CrossrefPubMedGoogle Scholar
• 3 Hall R I, Smith M S, Rocker G M. The systemic inflammatory response to cardiopulmonary bypass: Pathophysiological, therapeutic, and pharmacological considerations.  Anesth Analg. 1997;  85 766-782
  CrossrefPubMedGoogle Scholar
• 4 Cremer J, Martin M, Redl H. Systemic inflammatory response syndrome after cardiac operations.  Ann Thorac Surg. 1996;  61 1714-1720
  CrossrefPubMedGoogle Scholar
• 5 Pilz G, Kääb S, Kreuzer E, Werdan K. Evaluation of definitions and parameters for sepsis assessment in patients after cardiac surgery.  Infection. 1994;  22 8-17
  CrossrefPubMedGoogle Scholar
• 6 Tobias P S, Soldau K, Ulevitch R J. Identification of a lipid A binding site in the acute phase reactant lipopolysaccharide binding protein.  J Biol Chem. 1989;  264 10 867-10 871
  PubMedGoogle Scholar
• 7 Ramadori G, Meyer zum Buschenfelde K H, Tobias P S. et al . Biosynthesis of lipopolysaccharide-binding protein in rabbit hepatocytes.  Pathobiology. 1990;  58 89-94
  PubMedGoogle Scholar
• 8 Opal S M, Palardy J E, Marra M N. et al . Relative concentrations of endotoxin-binding proteins in body fluids during infection.  Lancet. 1994;  344 429-431
  CrossrefPubMedGoogle Scholar
• 9 Calvano S E, Thompson W A, Marra M N. et al . Changes in polymorphonuclear leukocyte surface and plasma bactericidal/permeability-increasing protein and plasma lipopolysaccharide-binding protein during endotoxemia or sepsis.  Arch Surg. 1994;  129 220-226
  PubMedGoogle Scholar
• 10 Pilz G, Kaab S, Kreuzer E. et al . Evaluation of definitions and parameters for sepsis assessment in patients after cardiac surgery.  Infection. 1994;  22 8-17
  CrossrefPubMedGoogle Scholar
• 11 Kuhn C, Muller-Werdan U, Schmitt D V. et al . Improved outcome of APACHE II score-defined escalating systemic inflammatory response syndrome in patients post cardiac surgery in 1996 compared to 1988 - 1990: the ESSICS-study pilot project.  Eur J Cardiothorac Surg. 2000;  17 30-37
  CrossrefPubMedGoogle Scholar
• 12 Bone R C. Sepsis, sepsis syndrome, and the systemic inflammatory response syndrome (SIRS).  JAMA. 1995;  273 155-156
  CrossrefPubMedGoogle Scholar
• 13 Fenton M J, Golenbock D T. LPS-binding proteins and receptors.  J Leukoc Biol. 1998;  64 25-32
  PubMedGoogle Scholar
• 14 Myc A, Buck J, Gonin J. et al . The level of lipopolysaccharide-binding protein is significantly increased in plasma in patients with the systemic inflammatory response syndrome.  Clin Diagnost Lab Immunol. 1997;  4 113-116
  PubMedGoogle Scholar
• 15 Martin T R, Rubenfeld G D, Ruzinski J T. et al . Relationship betwenn soluble CD14, lipopolysaccharide-binding protein, and the alveolar inflammatory response in patients with acute respiratory distress syndrome.  Am J Respir Crit Care Med. 1997;  155 937-944
  PubMedGoogle Scholar
• 16 Opal S M, Scannon P J, Vincent J L. et al . Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock.  J Infec Dis. 1999;  180 1584-1589
  PubMedGoogle Scholar
• 17 Fransen E J, Maessen J G, Hermens W T. et al . Peri-operative myocardial tissue injury and the release of inflammatory mediators in coronary artery bypass graft patients.  Cardiovasc Res. 2000;  45 853-859
  CrossrefPubMedGoogle Scholar
• 18 Assicot M, Gendrel D, Carsin H. et al . High serum procalcitonin concentrations in patients with sepsis and infection.  Lancet. 1993;  341 515-518
  CrossrefPubMedGoogle Scholar
• 19 Meisner M, Tschaikowsky K, Schmidt J. Procalcitonin (PCT) - Indications for a new diagnostic parameter of severe bacterial infection and sepsis in transplantation, immunosuppression and cardiac assist devices.  Cardiovasc Eng. 1996;  1 67-72
  PubMedGoogle Scholar
• 20 Hensel M, Volk T, Döcke W. et al . Hyperprocalcitonemia in patients with noninfectious SIRS and pulmonary dysfunction associated with cardiopulmonary bypass.  Anesthesiology. 1998;  89 93-104
  PubMedGoogle Scholar
• 21 deWerra I, Jaccard C, Corradin S B. et al . Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and pneumonia.  Crit Care Med. 1997;  25 607-613
  PubMedGoogle Scholar
• 22 Deng M C, Wiedner M. Erren M et al. Arterial and Venous Cytokine response to cardiopulmonary bypass for low risk CABG and relation to hemodynamics.  Eur J Cardio-thorac Surg. 1995;  9 22-29
  CrossrefPubMedGoogle Scholar
• 23 Casey L C. Role of cytokines in the pathogenesis of cardiopulmonary-induced multisystem organ failure.  Ann Thorac Surg. 1993;  56 92-96
  PubMedGoogle Scholar
• 24 Fransen E, Maessen J, Dentener M A. et al . Systemic inflammation present in pateints undergoing CABG without extracorporeal circulation.  Chest. 1998;  113 1290-1295
  PubMedGoogle Scholar
• 25 Steel D M, Whitehead A S. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein.  Immunol Today. 1994;  15 81-88
  CrossrefPubMedGoogle Scholar
• 26 Baumann H, Gauldie J. The acute phase response.  Immunol Today. 1994;  15 74-80
  CrossrefPubMedGoogle Scholar

Dr. Armin Sablotzki

Clinic of Anesthesiology and Intensive Care Medicine
Martin-Luther-University Halle/Wittenberg

Ernst-Grube-Straße 40

06120 Halle/Saale

Germany

Phone: +49 345 557 3300

Fax: +49 345 557 3306

Email: Sablotzki@aol.com